Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for sarilumab (Kevzara) for polymyalgia rheumatica (PMR) in adults who have had an inadequate response to corticosteroids, or who have experienced a relapse during corticosteroid taper.